Boston, MA and Rolle, Switzerland, April 23, 2024 ndash; SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in ...

United Kingdom-based liquid biopsy company Angle (OTCQX:ANPCY) has signed a supplier agreement with the biopharmaceutical ...

The potential impact of AI on healthcare is vast and transformative. With the use of AI platforms for diagnosing diseases ...

United Kingdom-based liquid biopsy company Angle (OTCQX:ANPCY) has signed a supplier agreement with the biopharmaceutical company AstraZeneca (NASDAQ:AZN) to tailor the existing Parsortix-based ...

Advanced Prostate Cancer Consensus Conference (APCCC) meeting featured a session on the management of metastatic CRPC (mCRPC) ...

Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq ...

Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq ...

Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq ...

Syndicate Bio is the first lab in Africa to adopt the MSK-ACCESS® assay via the SOPHiA DDM™ Platform, and the first company to make comprehensive genomic profiling and liquid biopsy widely ...

Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will ...

Liquid biopsy specialist Angle announced a supplier agreement with AstraZeneca on Wednesday to develop and validate a ...

ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D. GUILDFORD, SURREY / ACCESSWIRE / April 24, 2024 / ANGLE plc (AIM: ...